TRESITA-M 50/100Tablets
Diabetes CarePrescription

TRESITA-M 50/100

TRESITA-M 50/100 is a dual-action anti-diabetic formulation developed to support steady glycaemic control alongside diet and exercise. Presented as tablets and manufactured at WHO-GMP certified facilities under Pringston Life Sciences quality protocols.

TRESITA-M 50/100 is part of the Diabetes Care range — see all 21 Pringston formulations or request availability.

Composition

  • Sitagliptin 50 mg / 100 mg
  • Metformin 500 mg — Tablets

Form

Tablets

Use context

Indicated for glycaemic control support in Type 2 diabetes mellitus.

Enquire about this product

Frequently asked questions

More in Diabetes Care

PRIN-G1 / G2Tablets
Diabetes CarePrescription

PRIN-G1 / G2

Glimepiride 1 mg / 2 mg + Metformin 500 mg — Tablet

View details
PRIN-MV1 / MV2Tablets
Diabetes CarePrescription

PRIN-MV1 / MV2

Glimepiride 1 mg / 2 mg + Metformin SR 500 mg + Voglibose 0.2 mg — Tablets

View details

Browse other therapy areas

Diabetes CareCardiac & HypertensionGastro CarePain & OrthoRespiratory & AllergyWellness & Nutrition All products

Prescription (Schedule) products are listed for the information of registered medical practitioners only and are dispensed against a valid prescription. Compositions are transcribed exactly as printed on the carton.